Gadobenate dimeglumine (MultiHance®) in MR imaging of the CNS: Studies to assess the benefits of a high relaxivity contrast agent

Academic Radiology

Volumn 12, Issue 5 SUPPL. 1, 2005, Pages

  Essig, Marco ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOBUTROL; GADOLINIUM PENTETATE; GADOTERIC ACID;

ARTICLE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; STATISTICAL SIGNIFICANCE;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROVASCULAR CIRCULATION; CLINICAL TRIALS, PHASE II; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; SENSITIVITY AND SPECIFICITY;

EID: 23844462185     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2005.02.020     Document Type: Article

References (34)

1. M. Brant-Zawadski, D. Norman, T.H. Newton Magnetic resonance imaging of the brain the optimal screening technique Radiology 152 1984 71 77
2. L.R. Muroff, V.M. Runge The use of MR contrast in neoplastic disease of the brain Top Magn Reson Imaging 1995 7 1995 137 157
3. R.R. Edelmann, J.R. Hesselink, M.B. Zlatkin Clinical Magnetic Resonance Imaging Second Edition 1996 W.B. Saunders
4. M. Essig, M.V. Knopp, S.O. Schoenberg, H. Hawighorst, F. Wenz, J. Debus, G. van Kaick Contrast enhanced fast fluid-attenuated inversion-recovery (FLAIR) MR imaging in the assessment of primary glial tumors and brain metastases Radiology 210 1999 551 557
5. B.J. Erickson, N.G. Campeau, S.A. Schreiner, J.C. Buckner, B.P. O'Neill, J.R. O'Fallon Triple-dose contrast/magnetization transfer suppressed imaging of non-enhancing brain gliomas J Neurooncol 60 2002 25 29
6. G. Schneider, M.A. Kirchin, G. Pirovano Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases effect of dose on lesion detection and delineation J Magn Reson Imaging 14 2001 525 539
7. C. de Haën, M. Cabrini, L. Akhnana, D. Ratti, L. Calabi, L. Gozzini Gadobenate dimeglumine 0.5 M solution for injection (MultiHance): Pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium J Comput Assist Tomogr 23 suppl. 1 1999 161 168
8. W.T.C. Yuh, D.J. Fisher, J.D. Engelken MR evaluation of CNS tumors dose comparison study with gadopentetate dimeglumine and gadoteridol Radiology 180 1991 485 491
9. G. Myhr, P.A. Rinck, A. Børseth Gadodiamide injection and gadopentetate dimeglumine a double-blind study in MR imaging of the CNS Acta Radiologica 33 1992 405 409
10. J. Valk, P.R. Algra, C.J. Hazenberg, W.B.M. Slooff, M.G. Slavand A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system Neuroradiology 35 1993 173 177
11. M. Oudkerk, P.E. Sijens, E.J. van Beek, T.J. Kuijpers Safety and efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system Invest Radiol 30 1995 75 78
12. A. Greco, J.R. Parker, C.G. Ratcliffe, M.A. Kirchin, M.T. McNamara Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions Australas Radiol 45 2001 457 463
13. F.M. Cavagna, F. Maggioni, P.M. Castelli Gd chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 1997 780 796
14. M.V. Knopp, S.O. Schoenberg, C. Rehm Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography Phase I studies Invest Radiol 37 2002 706 715
15. G. Rosati, G. Pirovano, A. Spinazzi Interim results of phase II clinical testing of gadobenate dimeglumine Invest Radiol 29 1994 S183 S185
16. J. Ruscalleda, M.A. Kirchin, A. La Noce, G. Pirovano, A. Spinazzi Multihance in the assessment of intracranial tumors results of phase II clinical studies J Comput Assist Tomogr 23 Suppl. 1 1999 S19 S27
17. D. Balériaux, C. Colosimo, J. Ruscalleda Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine Neuroradiology 44 2002 191 203
18. G. Schneider, M.A. Kirchin, G. Pirovano Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases effect of dose on lesion detection and delineation J Magn Reson Imaging 14 2001 525 539
19. V.M. Runge, M.R. Armstrong, R.G. Barr A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology Invest Radiol 36 2001 65 71
20. V. Runge, J.R. Parker, M. Donovan Double-Blind, Efficacy Evaluation of Gadobenate Dimeglumine, a Gadolinium Chelate with Enhanced Relaxivity, in Malignant Lesions of the Brain Invest Radiol 37 2002 269 280
21. C. Colosimo, J. Ruscalleda, M. Korves Detection of intracranial metastases a multi-center, intra-patient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dose Invest Radiol 36 2001 72 81
22. M. Essig, M. Hartmann, K.P. Lodemann, O. Janson, V. Runge, M.V. Knopp Vergleich des Kontrastverhaltens von Gd-BOPTA und Gd-DTPA bei intraaxialen Hirntumoren Eine doppelblinde randomisierte intraindividuelle Vergleichsstudie Radiologe 41 2001 1063 1071 [in German]
23. Colosimo ISMRM or ARRS Abstract 2003 or ESMRMB abstract 2002
24. G. Bednarz, B. Downes, M. Werner-Wasik Rosenwasser RH. Combining stereotactic angiography and 3D time-of-flight magnetic resonance angiography in treatment planning for arteriovenous malformation radiosurgery Int J Radiat Oncol Biol Phys 46 2000 1149 1154
25. F. Ikawa, M. Sumida, T. Uozumi Demonstration of the venous systems with gadolinium-enhanced three-dimensional phase-contrast MR venography Neurosurg-Rev 18 1995 101 107
26. M. Essig, J. Reichenbach, L.R. Schad, S.O. Schönberg, M.V. Knopp, W.A. Kaiser High-resolution MR venography of cerebral arteriovenous malformations Magn Reson Imag 17 1999 1417 1425
27. H.-P. Schlemmer, T. Heß, J. Debus, M.V. Knopp, L.R. Schad, R. Engenhart TOF-MR-Angiographie bei strahlentherapeutisch behandelten zerebralen arteriovenösen Malformationen Radiologe 34 1994 447 453
28. J. Stevenson, E.A. Knopp, A.W. Litt MP-RAGE Subtraction venography A new technique Journal of Magnetic Resonance Imaging 5 1995 239 241
29. M. Duran, S.O. Schoenberg, W.T.C. Yuh, M.V. Knopp, G. van Kaick, M. Essig Cerebral arteriovenous malformations morphologic evaluation by ultrashort 3D gadolinium-enhanced MR angiography Eur Radiol 12 2002 2957 2964
30. Balériaux RSNA abstract
31. P.W. Schaefer, G.J. Hunter, J. He, L.M. Hamberg, A.G. Sorensen, L.H. Schwamm, W.J. Koroshetz, R.G. Gonzalez Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging Am J Neuroradiol 23 2002 1785 1794
32. M. Essig, F. Wenz, R. Scholdei, R. Bruening, C. Berchtenbreiter, M. Meurer, M.V. Knopp Effect of Contrast Media Dosage and Contrast Media Extravasation on Dynamic Susceptibility-Contrast Enhanced Dynamic Echo-Planar Imaging of Cerebral Gliomas Acta Radiol 43 2002 354 359
33. A. Bozzao, R. Floris, M.E. Baviera, A. Apruzzese, G. Simonetti Diffusion and perfusion MR imaging in cases of Alzheimer's disease correlations with cortical atrophy and lesion load Am J Neuroradiol 22 2001 1030 1036
34. M. Essig, K.P. Lodemann, M. LeHuu, S.O. Schonberg, M. Hubener, G. Van Kaick Comparison of MultiHance® and Gadovist® for cerebral MR perfusion imaging in healthy volunteers Radiologe 42 2002 909 915